摘要 |
The use of xanthine derivatives of the formula I <IMAGE> and of their physiologically tolerated salts, where R<1> is oxoalkyl, hydroxyalkyl or alkyl, R<2> is hydrogen or alkyl and R<3> is hydrogen, alkyl, oxoalkyl or an alkyl which has up to 6 carbon atoms and whose carbon chain is interrupted by an oxygen atom, for the manufacture of medicaments for the treatment of disorders which may occur after craniocerebral trauma, is described. |
申请人 |
HOECHST AG, 65929 FRANKFURT, DE |
发明人 |
SCHUBERT, HANS-PETER, PROF., DR., W-8031 WOERTHSEE-STEINEBACH, DE;GROME, JOHN J., DR., W-6200 WIESBADEN, DE;KITTNER, BARBARA, DR., W-6200 WIESBADEN, DE;RUDOLPHI, KARL, DR., W-6500 MAINZ, DE;GEBERT, ULRICH, DR., W-6246 GLASHUETTEN/TANUS 2, DE |